AbbVie
ABBV
#26
Rank
ยฃ299.93 B
Marketcap
ยฃ169.71
Share price
-1.15%
Change (1 day)
26.30%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ51.60 Billion

According to AbbVie's latest financial reports the company's total debt is ยฃ51.60 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ53.50 B14.79%
2023-12-31ยฃ46.61 B-10.87%
2022-12-31ยฃ52.29 B-7.94%
2021-12-31ยฃ56.80 B-10.02%
2020-12-31ยฃ63.13 B24.07%
2019-12-31ยฃ50.88 B60.24%
2018-12-31ยฃ31.75 B14.85%
2017-12-31ยฃ27.64 B-7.4%
2016-12-31ยฃ29.85 B39.71%
2015-12-31ยฃ21.37 B122.16%
2014-12-31ยฃ9.61 B7.78%
2013-12-31ยฃ8.92 B-7.95%
2012-12-31ยฃ9.69 B31297.55%
2011-12-31ยฃ30.88 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ45.67 B-11.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ38.31 B-25.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ31.90 B-38.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ40.97 B-20.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ18.72 B-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ4.94 B-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.91 B-65.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
ยฃ24.49 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.32 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA